Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Georgian Med News ; (347): 168-176, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38609136

RESUMO

The idea that obesity and cardiovascular diseases together are considered for a sizable share of adult global morbidity and mortality is supported by epidemiological data. They have intricate systems in which environmental and genetic variables interact, including nutrition. As an environmental component, nutrition has a major and well-known role in managing health and preventing obesity and disorders connected to obesity, such as cardiovascular disease (CVD). Nonetheless, people with the same food pattern but obese exhibit a notable difference in CVD. This variance might be explained by the various genetic polymorphisms which gave rise to the field of nutrigenetics. The discipline known as nutritional genomics, or nutrigenetics, examines and describes gene variants linked to varying reactions to particular nutrients and links these variations to various disorders, including obesity-related cardiovascular disease (CVD). Therefore, tailored nutrition advice depending on a person's genetic background could enhance the results of a particular dietary intervention and offer a novel dietary technique to enhance health by lowering obesity and cardiovascular disease. With these suppositions, it seems reasonable to assume that understanding food and gene interactions will provide more targeted and efficacious dietary treatments in preventing obesity and CVD by nutrigenetics-based personalized nutrition. In addition to elucidating the connection between diet and gene expression and the major nutrition-related genes involved in obesity and CVD, this research seeks to provide a concise summary of the greater significant genes linked to obesity and CVD.


Assuntos
Doenças Cardiovasculares , Sistema Cardiovascular , Humanos , Adulto , Doenças Cardiovasculares/genética , Doenças Cardiovasculares/prevenção & controle , Nutrigenômica , Obesidade/genética , Estado Nutricional
2.
Arch Razi Inst ; 76(5): 1279-1287, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-35355734

RESUMO

Rosmarinic acid was obtained from methanolic extract of Mentha piperita L. under a reflux condenser. The current study aimed to evaluate the in vitro antioxidant activities and rosmarinic acid levels of the methanol extracts of M. piperita. The analysis of the sample by high-performance liquid chromatography technique (HPLC) indicated that rosmarinic acid was present in high concentration 1.9 mg/mL in the extract. Purification was carried out by column chromatography to give 0.020 g from 1 g of crude extract, and then the antioxidant activity of purified rosmarinic acid was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH), H2O2 scavenging, and REDOX methods. It was revealed that the anti-oxidant potential of the rosmarinic acid extract was greater than 95% (at 100 µg/mL) for DPPH assay and 87.83% (at 100 µg/ml) for H2O2 scavenging assay. This study was performed by using a reflux methanolic extraction of M. piperita. This possible instructional technique proved to be a quick and successful method for retaining the antioxidant properties of rosmarinic acid. The rosmarinic acid content was determined using HPLC.


Assuntos
Antioxidantes , Mentha piperita , Animais , Cinamatos , Depsídeos , Peróxido de Hidrogênio , Mentha piperita/química , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Ácido Rosmarínico
3.
Vaccine ; 37(49): 7207-7212, 2019 11 20.
Artigo em Inglês | MEDLINE | ID: mdl-31635975

RESUMO

A total of 143 horses were included in a study to test a commercial vaccine against Lyme borreliosis. The vaccine contained three different antigens (outer surface protein A, OspA) to prevent the infection with spirochetes - B.burgdorferi sensu stricto, B. afzelii and B. garinii. Horses in Group A (49 animals) received two vaccinations on days 0 and 14 and a booster on day 365, whereas 50 horses in Group B received an additional booster vaccination on day 180. Group C (44 animals) was not immunized. Total antibody levels and specific OspA antibody responses were assessed quantitatively and qualitatively in two-month intervals over 13-month period. Vaccinees in Groups A and B developed high OspA antibodies levels, whereas horses in Group C did not show specific antibody responses. The additional vaccination applied in Group B enhanced the specific OspA antibody response significantly and prevented its rapid decline.


Assuntos
Anticorpos Antibacterianos/sangue , Doenças dos Cavalos/prevenção & controle , Cavalos/imunologia , Vacinas contra Doença de Lyme/imunologia , Doença de Lyme/prevenção & controle , Doença de Lyme/veterinária , Animais , Antígenos de Superfície/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Vacinas Bacterianas/imunologia , Borrelia burgdorferi/imunologia , Doenças dos Cavalos/imunologia , Doenças dos Cavalos/microbiologia , Imunidade Humoral/fisiologia , Esquemas de Imunização , Imunogenicidade da Vacina/imunologia , Lipoproteínas/imunologia , Vacinas contra Doença de Lyme/administração & dosagem , Vacinação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA